Vraylar 3 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB26FGLZU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,167
Award facts
- Contract value 100% obligated
- $13,166.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Vraylar 3 mg capsules (30-count) with a contract ceiling value of $13,166.83. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The order is set for ultimate completion by October 27, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle for military and federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts primarily with the Defense Logistics Agency and its Medical Supply Chain. The company supplies a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a leading vendor in federal medical procurement, AmerisourceBergen consistently demonstrates capability to fulfill competitively awarded contracts across varying order values, from small transactions to substantial orders exceeding $45,000. The Vraylar neurological treatment delivery represents routine pharmaceutical procurement activity within the company's established federal contracting relationship.
Quick answers
Who was awarded contract SPE2DB26FGLZU?
SPE2DB26FGLZU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FGLZU worth?
The government has obligated $13,167 on SPE2DB26FGLZU.
Is contract SPE2DB26FGLZU an order under another contract?
Yes. SPE2DB26FGLZU is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB26FGLZU competed?
The extent of competition for SPE2DB26FGLZU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award